Otros idiomas U.S. Stem Cell, Inc.

Acciones

USRM

US90350U1007

Mercado cerrado - OTC Markets Otros sitios de cotización 21:42:59 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,000001 ^USD	-99,00 %		0,00 %	0,00 %

2023	U.S. Stem Cell, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2022	CI
2023	U.S. Stem Cell, Inc. El auditor plantea dudas sobre la "empresa en funcionamiento	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	14/04/23
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	14/04/23
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	09/11/22
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22
U.S. STEM CELL, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	08/07/22
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	23/05/22
U.S. Stem Cell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/05/22
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
U.S. STEM CELL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	31/03/22
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	31/03/22
U S Stem Cell : Material Event - Form 8-K/A	09/03/22
U.S. STEM CELL, INC. Other Events (form 8-K/A)	09/03/22
U S Stem Cell : Mark Borman appointed Chairman of the Board of USRM	09/03/22
U.S. STEM CELL, INC. : Other Events (form 8-K)	09/03/22
U.S. Stem Cell, Inc. Announces Management Changes	09/03/22
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	09/11/21
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	09/11/21
U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation	18/10/21
U S Stem Cell : NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	12/08/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas U.S. Stem Cell, Inc.

Acciones

USRM

US90350U1007

Otros idiomas

Filtros